AOP Orphan is a European pioneer in the development, production and marketing of treatments for people with rare diseases also known as orphan diseases.
“It is a privilege to apply my pharmaceutical and business education and more than 25 years of professional experience to improve the lives of people with rare diseases in Lithuania. We have been operating here since 2009 and will continue to provide innovative and efficient treatment solutions!"
AOP Orphan is fully dedicated to pharmaceutical and clinical development as well as commercialization of drugs for more than 20 years already.
Our motivation at AOP Orphan is to help patients who suffer from rare diseases. We achieve this cooperating with stakeholders of the Lithuanian health care system. Partnerships within pharmaceutical and health care industry are crucial for finding and providing solutions for patients, especially in the treatment of orphan diseases.
Lithuania occupies a special position among many countries where AOP Orphan is represented. In this market, the company began its development in 2009 with a local team in the Marketing & Sales, and Medical for all three therapeutic divisions.